Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Int J Antimicrob Agents ; 62(2): 106885, 2023 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-37302771

RESUMEN

OBJECTIVES: Oral combination of clindamycin and rifampicin is relevant for the treatment of staphylococcal osteoarticular infection (SOAIs). However, rifampicin induces CYP3A4, suggesting a pharmacokinetic interaction with clindamycin with unknown pharmacokinetic/pharmacodynamic (PK/PD) consequences. This study aimed to quantify clindamycin PK/PD markers before and during rifampicin co-administration in SOAI. METHODS: Patients with SOAI were included. After initial intravenous antistaphylococcal treatment, oral therapy was started with clindamycin (600 or 750 mg t.i.d.), followed by addition of rifampicin 36 h later. Population PK analysis was performed using the SAEM algorithm. PK/PD markers were compared with and without rifampicin co-administration, each patient being his own control. RESULTS: In 19 patients, clindamycin median (range) trough concentrations were 2.7 (0.3-8.9) mg/L and <0.05 (<0.05-0.3) mg/L before and during rifampicin administration, respectively. Rifampicin co-administration increased clindamycin clearance by a factor 16 and reduced the AUC0-8h/MIC by a factor 15 (P < 0.005). Clindamycin plasma concentrations were simulated for 1000 individuals, without and with rifampicin. Against a susceptible Staphylococcus aureus strain (clindamycin MIC 0.0625 mg/L), >80% of individuals would reach all proposed PK/PD targets without co-administration of rifampicin, even with low clindamycin dose. For the same strain, when rifampicin was co-administered, the probability to reach clindamycin PK/PD targets dropped to 1% for %fT>MIC = 100% and to 6% for AUC0-24h/MIC > 60, even with high clindamycin dose. CONCLUSION: Rifampicin co-administration with clindamycin has a high impact on clindamycin exposure and PK/PD targets in SOAI, which could result in clinical failure even for fully susceptible strains.


Asunto(s)
Rifampin , Infecciones Estafilocócicas , Humanos , Rifampin/uso terapéutico , Clindamicina/uso terapéutico , Antibacterianos/farmacología , Antibacterianos/uso terapéutico , Infecciones Estafilocócicas/tratamiento farmacológico , Staphylococcus aureus , Pruebas de Sensibilidad Microbiana
2.
Rev Med Interne ; 43(6): 342-346, 2022 Jun.
Artículo en Francés | MEDLINE | ID: mdl-35643787

RESUMEN

INTRODUCTION: The rate of vaccination in HCWs in France remains low. We aimed to analyze the attitude and beliefs of HCWs toward influenza vaccination in Internal Medicine wards. METHODS: We conducted a cross-sectional survey of HCWs in the departments of Internal Medicine of two tertiary hospitals in France. An anonymous questionnaire designed for this study was used to collect demographic, health beliefs and attitudes, and medical knowledge related to the influenza and influenza vaccine. The survey started shortly prior the 2019 influenza season. RESULTS: The surveys were completed by 158 (29[18-62] years-old ; 75.9% female ; 69.6% non-medical workers) of 187 (84.5%) HCWs. Overall, influenza vaccination coverage rate was 50.6% (n=80/158). Higher vaccination coverage was found in physician and in HCWs who had a better knowledge about the virus transmission. The reason to fulfill vaccination recommendations was to protect the patients, their relatives and themselves for more than 80% of HCWs compliant to vaccination recommendation. More than a third of HCWs (n=59/158; 37.3%) refused to be vaccinated or hesitated. Among them, 12 (12/59, 20.3%) believed that influenza vaccine could cause flu. The main reasons for reluctant HCWs to eventually accept to be vaccinated were a mandatory vaccination program and the demonstration of a better vaccine efficacy to prevent the disease. CONCLUSION: Influenza vaccination coverage among HCWs in Internal Medicine remains low. Education campaigns targeting in priority nurses and nurse assistants is mandatory to improve the compliance of HCWs to vaccination recommendation.


Asunto(s)
Vacunas contra la Influenza , Gripe Humana , Adolescente , Adulto , Actitud del Personal de Salud , Estudios Transversales , Femenino , Personal de Salud , Humanos , Vacunas contra la Influenza/uso terapéutico , Gripe Humana/prevención & control , Masculino , Persona de Mediana Edad , Encuestas y Cuestionarios , Vacunación , Adulto Joven
3.
Rev Med Interne ; 41(11): 727-731, 2020 Nov.
Artículo en Francés | MEDLINE | ID: mdl-32753244

RESUMEN

INTRODUCTION: A unique structure devoted to post-acute and rehabilitation care for patients under 75 with multiple comorbidities has been created within the Department of Internal Medicine, Bichat Hospital, Paris. We aim to report on demographic factors, clinical characteristics and outcomes of patients hospitalized in this pilot structure. METHODS: All consecutive adult patients admitted between May 2017 and May 2018 were retrospectively reviewed. RESULTS: Analysis was performed on 61 (61 [24-75] years-old) admitted patients. The median length of hospital stays was 108 [13-974] days. At admission, the median Charlson comorbidity index was 6 [0-12] predicting a 10-year survival of 21 [0-99]%. Most patients were unemployed (83.6%) and had very low-income (< national minimum wage in 65.6% of cases). At hospital discharge, most patients (85.4%) were able to return home. The complete resolution of health problems occurred in most cases (65.6%) and was associated with a lower probability of both hospital readmission and death 1-year after discharge. CONCLUSION: The structure served a high percentage of patients with major and complex health needs but limited access to care due to individual disabilities, low-income and underinsured status. However, despite major health disorders, functional limitations, and vulnerability, admission improved patient outcomes and reduced excess hospital readmissions in most cases.


Asunto(s)
Cuidados Posteriores , Hospitales de Rehabilitación , Rehabilitación , Atención Subaguda , Adulto , Cuidados Posteriores/métodos , Cuidados Posteriores/organización & administración , Cuidados Posteriores/estadística & datos numéricos , Factores de Edad , Anciano , Comorbilidad , Femenino , Hospitales de Rehabilitación/organización & administración , Hospitales de Rehabilitación/normas , Hospitales de Rehabilitación/estadística & datos numéricos , Humanos , Tiempo de Internación/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Paris/epidemiología , Readmisión del Paciente/estadística & datos numéricos , Proyectos Piloto , Rehabilitación/métodos , Rehabilitación/organización & administración , Rehabilitación/estadística & datos numéricos , Estudios Retrospectivos , Atención Subaguda/métodos , Atención Subaguda/organización & administración , Atención Subaguda/estadística & datos numéricos , Adulto Joven
4.
Rev Med Interne ; 39(6): 386-392, 2018 Jun.
Artículo en Francés | MEDLINE | ID: mdl-29571580

RESUMEN

INTRODUCTION: Vaccination against influenza virus and Streptococcus pneumoniae is a global health priority and authorities, on the basis of recent publications, have recently updated French recommendations. The aim of this study was to describe the influenzae and pneumococcal vaccination's rate in an internal medicine ward. MATERIAL AND METHODS: All patients consecutively hospitalized during a 10 week-period in an internal medicine ward were included. The reasons for non-vaccination and the impact of an educational program for corrective measures were reported. RESULTS: Overall, 198 consecutive patients were included; 93 (47%) were immunocompromised; 142 (71.2%) had an indication for pneumococcal vaccination and 171 (86.4%) for influenza vaccination but only 16.2% and 55% of them were vaccinated against these microorganisms, respectively. Prior pneumococcal vaccination was more frequently observed in immunocompromised patients than in non-immunocompromised patients (21.1 versus 6.4%; P=0.029), but no significant difference was observed for influenza vaccine. Corrective measures were initiated in 46 patients (39%), non-immunized against S. pneumoniae. CONCLUSION: These results underline the very low prevalence of pneumococcal vaccination rate in at-risk hospitalized patients, as compared with influenza, despite recent recommendations.


Asunto(s)
Gripe Humana/prevención & control , Medicina Interna , Admisión del Paciente/estadística & datos numéricos , Neumonía Neumocócica/prevención & control , Vacunación/estadística & datos numéricos , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Niño , Preescolar , Femenino , Francia/epidemiología , Unidades Hospitalarias/estadística & datos numéricos , Humanos , Huésped Inmunocomprometido , Vacunas contra la Influenza/uso terapéutico , Gripe Humana/epidemiología , Medicina Interna/estadística & datos numéricos , Masculino , Persona de Mediana Edad , Vacunas Neumococicas/uso terapéutico , Neumonía Neumocócica/epidemiología , Prevalencia , Streptococcus pneumoniae/inmunología , Adulto Joven
6.
Med Mal Infect ; 47(3): 206-220, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28336304

RESUMEN

Infectious encephalitis is a severe disease leading to a high mortality and morbidity. The most frequent causes include Herpes simplex virus, Varicella Zoster virus, Listeria monocytogenes, and Mycobacterium tuberculosis. Urgent treatment is required (anti-infective therapy and nonspecific supportive care). The aim of this study was to define treatment strategy, empirical and after microbiological documentation at 48hours, through a systematic literature review.


Asunto(s)
Encefalitis Infecciosa/terapia , Adulto , Antiinfecciosos/uso terapéutico , Anticonvulsivantes/uso terapéutico , Daño Encefálico Crónico/prevención & control , Cuidados Críticos , Diagnóstico Diferencial , Manejo de la Enfermedad , Francia/epidemiología , Hospitalización , Humanos , Soluciones Hipertónicas/uso terapéutico , Hipotermia Inducida , Encefalitis Infecciosa/complicaciones , Encefalitis Infecciosa/epidemiología
7.
Rev Med Interne ; 36(12): 854-8, 2015 Dec.
Artículo en Francés | MEDLINE | ID: mdl-25912080

RESUMEN

INTRODUCTION: Bovine ketosis is a rare cause of metabolic acidosis. It is a starvation ketosis that appears in lactating woman. CASE REPORT: A 29-year-old woman had a previous gastric surgery one month ago while breastfeeding her 6-month child. She presented to emergency with dyspnea, fatigue, weight loss and anorexia. The explorations revealed a serious metabolic acidosis with a high anion gap, for which all other causes have been eliminated. CONCLUSION: A restrictive diet in lactating patients is a major risk of ketosis or bovine ketosis. Medico-surgical treatment of obesity during lactation seems unreasonable. Breastfeeding should be systematically sought before a medical and surgical management of obesity. With the spread of bariatric surgery, starvation ketosis is a cause of metabolic acidosis not to ignore.


Asunto(s)
Lactancia Materna , Cetosis , Lactancia/metabolismo , Complicaciones Posoperatorias , Adulto , Cirugía Bariátrica , Ayuno , Femenino , Humanos , Cetosis/diagnóstico , Cetosis/etiología , Complicaciones Posoperatorias/diagnóstico , Complicaciones Posoperatorias/etiología
8.
Rev Med Interne ; 35(10): 676-9, 2014 Oct.
Artículo en Francés | MEDLINE | ID: mdl-24290029

RESUMEN

INTRODUCTION: Adulterants are compounds added to street drugs to increase profits for the seller. Levamisole, a veterinary antihelminthic agent, has become the most common adulterant of cocaine. The prevalence of levamisole in samples of cocaine is increasing. Levamisole can lead to neutropenia and to a dramatic vasculopathy and even vasculitis of small and medium-size blood vessels. CASE REPORT: We here reported the first French case of levamisole related toxicity, due to cocaine use in a 50-year-old man, revealed by fever and agranulocytosis, high titters of antineutrophil cytoplasmic antibodies (ANCA), anticoagulant and positive Coombs tests. Outcome was slowly favorable with exposition withdrawal. CONCLUSION: Clinicians should be aware that agranulocytosis or vasculitis or vasculopathy could be related to levamisole toxicity in individuals who use cocaine.


Asunto(s)
Agranulocitosis/inducido químicamente , Trastornos Relacionados con Cocaína/complicaciones , Contaminación de Medicamentos , Consumidores de Drogas , Levamisol/envenenamiento , Vasculitis/inducido químicamente , Agranulocitosis/complicaciones , Agranulocitosis/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Vasculitis/complicaciones , Vasculitis/diagnóstico
9.
J Hosp Infect ; 84(4): 294-9, 2013 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23846237

RESUMEN

BACKGROUND: Extended-spectrum ß-lactamase-producing Escherichia coli (ESBLEC) is an increasing cause of hospital-acquired infection. Risk factors for ESBLEC colonization and infection have been reported, but information is lacking about the risk factors for acquiring ESBLEC infection in patients with prior colonization. AIM: To identify risk factors for development of infection in patients colonized with ESBLEC. METHODS: A retrospective study was performed at Hôpital Necker-Enfants Malades, Paris from 2007 to 2010. A multi-variable model was created to compare a group of patients with nosocomial ESBLEC infection following documented ESBLEC colonization with a control group of patients colonized with ESBLEC (case-control design). FINDINGS: In total, 118 patients were included: 40 (26 adults, 14 children) with colonization and infection and 78 (51 adults, 27 children) with colonization alone. The median time from colonization to infection was 12.5 days [25-75% confidence interval (CI) 5-40]. ESBLEC infections included urinary tract infection (85%), bacteraemia (7.5%) and lower respiratory tract infection (7.5%). On multi-variate analysis, use of ß-lactam/ß-lactamase inhibitor prior to infection [odds ratio (OR) 3.2, 95% CI 1.073-9.864); P = 0.037] and urinary catheterization were reported as risk factors for ESBLEC infection in colonized patients (OR 5.2, 95% CI 1.984-13.569; P = 0.0008). CONCLUSION: Identification of these risk factors will be helpful to identify patients colonized with ESBLEC who will require antibiotics for ESBLEC in the case of nosocomial infection. Limiting the use of specific antibiotics and controlling the duration of urinary catheterization will be helpful for prevention of ESBLEC infection.


Asunto(s)
Infección Hospitalaria/microbiología , Infecciones por Escherichia coli/microbiología , Escherichia coli/enzimología , beta-Lactamasas/metabolismo , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antibacterianos/uso terapéutico , Estudios de Casos y Controles , Cateterismo , Niño , Preescolar , Infección Hospitalaria/epidemiología , Infección Hospitalaria/prevención & control , Utilización de Medicamentos , Escherichia coli/aislamiento & purificación , Infecciones por Escherichia coli/epidemiología , Infecciones por Escherichia coli/prevención & control , Femenino , Humanos , Lactante , Masculino , Persona de Mediana Edad , Paris/epidemiología , Estudios Retrospectivos , Factores de Riesgo , Adulto Joven
10.
Cerebrovasc Dis ; 35(4): 327-36, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23615478

RESUMEN

BACKGROUND: Cerebral complications are well-identified causes of morbidity and mortality in patients with infective endocarditis (IE). Few studies have analysed the impact of brain magnetic resonance imaging (MRI) in IE patients with neurological manifestations. OBJECTIVES: The aims of this study were to assess the MRI contribution to the management of patients with IE neurological manifestations and to compare cerebral CT and MRI findings. MATERIAL AND METHODS: Patients with definite or probable IE and neurological manifestations were prospectively enrolled from 2005 to 2008, in a university hospital (Bichat Claude Bernard Hospital, Paris). Clinical and radiological characteristics and echocardiographic findings were systematically recorded. Brain MRI with angiography was performed and compared to available CT scans. The contribution of MRI results to cerebral involvement staging and to therapeutic plans was evaluated. RESULTS: Thirty patients, 37-89 years old, were included. Nineteen suffered from pre-existing heart disease. Blood cultures were positive in 29 cases and the main micro-organisms were streptococci (n = 14) and staphylococci (n = 13). The IE was mainly located on mitral (n = 15) and aortic valves (n = 13). Neurological events were strokes (n = 12), meningitis (n = 5), seizures (n = 1), impaired consciousness (n = 11) and severe headache (n = 1). MRI findings included ischaemic lesions (n = 25), haemorrhagic lesions (n = 2), subarachnoid haemorrhage (n = 5), brain abscess (n = 6), mycotic aneurysm (n = 7), vascular occlusion (n = 3) and cerebral microbleeds (n = 17). In 19/30 cases, neurological manifestations were observed before the diagnosis of IE. MRI was more sensitive than CT scan in detecting both clinically symptomatic cerebral lesions (100 and 81%, respectively) and additional asymptomatic lesions (50 and 23%, respectively). Therapeutic plans were modified according to MRI results in 27% of patients: antibiotherapy regimen modifications in 7% (switch for molecules with high cerebral diffusion) and surgical plan modifications in 20% (indication of valvular replacement due to the embolic nature of the vegetations revealed by MRI or postponement of surgery due to haemorrhagic lesions). None of the 16/30 (51%) operated-on patients experienced postoperative neurological worsening. In-hospital death occurred in 4 patients. CONCLUSION: In patients with IE neurological manifestations, MRI revealed a broader involvement of the brain (type and number of lesions) than indicated by clinical signs and/or CT scan. With a better disease staging of neurological manifestations, MRI brain imaging may help in patient management and the decision-making process especially for cardiac surgery indication and timing of valve replacement.


Asunto(s)
Encefalopatías/diagnóstico , Encéfalo/irrigación sanguínea , Encéfalo/patología , Angiografía Cerebral/métodos , Arterias Cerebrales/patología , Imagen de Difusión por Resonancia Magnética , Endocarditis Bacteriana/complicaciones , Angiografía por Resonancia Magnética , Adulto , Anciano , Anciano de 80 o más Años , Encéfalo/diagnóstico por imagen , Encefalopatías/etiología , Encefalopatías/mortalidad , Encefalopatías/patología , Encefalopatías/terapia , Arterias Cerebrales/diagnóstico por imagen , Trastornos Cerebrovasculares/diagnóstico , Trastornos Cerebrovasculares/etiología , Ecocardiografía , Endocarditis Bacteriana/diagnóstico , Endocarditis Bacteriana/microbiología , Endocarditis Bacteriana/mortalidad , Endocarditis Bacteriana/terapia , Femenino , Hospitales Universitarios , Humanos , Masculino , Persona de Mediana Edad , Paris , Valor Predictivo de las Pruebas , Pronóstico , Estudios Prospectivos , Tomografía Computarizada por Rayos X
11.
Recent Pat Antiinfect Drug Discov ; 6(1): 45-53, 2011 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-21192777

RESUMEN

Although carbapenem antibiotics are one of the most effective agents in the treatment of nosocomial infections caused by Gram-negative bacteria, their use is threatened by the emergence of antibiotic resistance. The bacterial resistance to carbapenems parallels their increasing use and has dramatic clinical implications such as increase in mortality and cost of care. This article reviews recently published patents claiming for carbapenem antibacterial agents. New forms including crystalline forms with high oral bioavailability and modified spectrum including methicillin-resistant Staphylococci are some of new patents described in this review.


Asunto(s)
Antibacterianos/farmacología , Carbapenémicos/farmacología , Infección Hospitalaria/tratamiento farmacológico , Infecciones por Bacterias Gramnegativas/tratamiento farmacológico , Animales , Antibacterianos/química , Antibacterianos/uso terapéutico , Carbapenémicos/química , Carbapenémicos/uso terapéutico , Infección Hospitalaria/microbiología , Formas de Dosificación , Farmacorresistencia Microbiana , Humanos , Patentes como Asunto
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA